185 related articles for article (PubMed ID: 14969090)
1. [Long-term efficacy and safety of combined topical antiglaucoma therapy--timolol & unoprostone vs. betaxolol & unoprostone].
Ohtake Y; Tanino T; Kimura I; Mashima Y; Oguchi Y
Nippon Ganka Gakkai Zasshi; 2004 Jan; 108(1):23-8. PubMed ID: 14969090
[TBL] [Abstract][Full Text] [Related]
2. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
[TBL] [Abstract][Full Text] [Related]
3. The effects on the intraocular pressure and visual field resulting from a switch in the treatment from timolol to betaxolol.
Miki H; Miki K
J Ocul Pharmacol Ther; 2004 Dec; 20(6):509-17. PubMed ID: 15684810
[TBL] [Abstract][Full Text] [Related]
4. The effects of unoprostone isopropyl 0.12% and timolol maleate 0.5% on diurnal intraocular pressure.
Stewart WC; Stewart JA; Kapik BM
J Glaucoma; 1998 Dec; 7(6):388-94. PubMed ID: 9871860
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma.
Sponsel WE; Paris G; Trigo Y; Pena M
Am J Ophthalmol; 2002 Oct; 134(4):552-9. PubMed ID: 12383812
[TBL] [Abstract][Full Text] [Related]
6. Influence of topical betaxolol and timolol on visual field in Japanese open-angle glaucoma patients.
Araie M; Azuma I; Kitazawa Y
Jpn J Ophthalmol; 2003; 47(2):199-207. PubMed ID: 12738555
[TBL] [Abstract][Full Text] [Related]
7. Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.
Sharpe ED; Henry CJ; Mundorf TK; Day DG; Stewart JA; Jenkins JN; Stewart WC
Eye (Lond); 2005 Jan; 19(1):35-40. PubMed ID: 15094733
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of unoprostone isopropyl as an adjunct to topical beta-blocker in patients with open angle glaucoma: a-6-month study.
Leelachaikul Y; Euswas A
J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S100-4. PubMed ID: 16681060
[TBL] [Abstract][Full Text] [Related]
9. Low incidence of iris pigmentation and eyelash changes in 2 randomized clinical trials with unoprostone isopropyl 0.15%.
McCarey BE; Kapik BM; Kane FE;
Ophthalmology; 2004 Aug; 111(8):1480-8. PubMed ID: 15288975
[TBL] [Abstract][Full Text] [Related]
10. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
Martínez A; Sánchez M
Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF2 alpha metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension.
Nordmann JP; Rouland JF; Mertz BP
Curr Med Res Opin; 1999; 15(2):87-93. PubMed ID: 10494491
[TBL] [Abstract][Full Text] [Related]
12. [Effect of betaxolol and timolol on visual fields in glaucoma patients].
Messmer C; Stümpfig D; Flammer J
Klin Monbl Augenheilkd; 1991 May; 198(5):330-1. PubMed ID: 1886348
[TBL] [Abstract][Full Text] [Related]
13. Longterm effect of topical beta-blockers on intraocular pressure and visual field sensitivity in ocular hypertension and chronic open-angle glaucoma.
Collignon-Brach J
Surv Ophthalmol; 1994 May; 38 Suppl():S149-55. PubMed ID: 7940136
[TBL] [Abstract][Full Text] [Related]
14. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of UF-021 (Rescula; isopropyl unoprostone).
Yamamoto T; Kitazawa Y; Azuma I; Masuda K
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S99-103. PubMed ID: 9154284
[TBL] [Abstract][Full Text] [Related]
16. The favorable effect of topical betaxolol and timolol on glaucomatous visual fields: a 2-year follow-up study.
Vainio-Jylhä E; Vuori ML
Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):100-4. PubMed ID: 9987624
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of isopropyl unoprostone (Rescula), in the adjunctive treatment of primary open angle glaucoma].
Zarnowski T; Kawa P; Jurkowska-Dudzińska J; Zagórski Z
Klin Oczna; 2001; 103(1):13-5. PubMed ID: 11605578
[TBL] [Abstract][Full Text] [Related]
18. [Long-term effects of isopropyl unoprostone monotherapy on intraocular pressure and visual field for normal-tension glaucoma and primary open-angle glaucoma patients].
Saito Y; Saeki T; Sugiyama K
Nippon Ganka Gakkai Zasshi; 2006 Sep; 110(9):717-22. PubMed ID: 17025229
[TBL] [Abstract][Full Text] [Related]
19. A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma.
Watson PG; Barnett MF; Parker V; Haybittle J
Br J Ophthalmol; 2001 Aug; 85(8):962-8. PubMed ID: 11466256
[TBL] [Abstract][Full Text] [Related]
20. Intraocular pressure-lowering efficacy of latanoprost in patients with normal-tension glaucoma or primary open-angle glaucoma.
Tamada Y; Taniguchi T; Murase H; Yamamoto T; Kitazawa Y
J Ocul Pharmacol Ther; 2001 Feb; 17(1):19-25. PubMed ID: 11322634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
